Guam vs Togo: The number of people with susceptibility test result for rifampicin
Guam
92.11
in 2021
Togo
92.42
in 2021
Guam rank
62nd
Togo rank
61st
The number of people with susceptibility test result for rifampicin over time
- Guam
- Togo
How they compare
Togo currently reports 92.42 against 92.11 in Guam, a difference of 0.31.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Guam ahead.
Guam ranks 62nd and Togo ranks 61st of 146 countries.
Guam has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guam | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 98.77 | 36.81 | 61.97 | Guam |
| 2020s | 94.77 | 90.74 | 4.03 | Guam |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Guam or Togo?
- Togo, at 92.42 against 92.11 in Guam as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Guam and Togo?
- 0.31, with Togo ahead.
- How many years of comparable data are there for Guam and Togo?
- 5 years are reported by both, from 2017 to 2021.
- How do Guam and Togo rank globally for the number of people with susceptibility test result for rifampicin?
- Guam ranks 62nd and Togo ranks 61st of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.